600200.SS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:00):

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China...

Stats
Dagens volum	36.39M
Gjennomsnittsvolum	51.17M
Markedsverdi	7.78B
EPS	CNY0 ( 2023-10-30 )
Neste inntjeningsdato	( CNY0 ) 2024-05-16
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-84.31
ATR14	CNY0.0140 (0.13%)

Volum Korrelasjon

Lang: 0.02 (neutral)

Kort: 0.18 (neutral)

Signal:(28.104) Neutral

JiangSu WuZhong Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

JiangSu WuZhong Korrelasjon - Valuta/Råvare

0.41
( neutral )

-0.07
( neutral )

0.00
( neutral )

-0.34
( neutral )

0.79
( moderate )

-0.01
( neutral )

JiangSu WuZhong Økonomi

Annual	2023
Omsetning:	CNY2.23B
Bruttogevinst:	CNY506.68M (22.76 %)
EPS:	CNY-0.100

FY	2023
Omsetning:	CNY2.23B
Bruttogevinst:	CNY506.68M (22.76 %)
EPS:	CNY-0.100

FY	2022
Omsetning:	CNY2.03B
Bruttogevinst:	CNY579.66M (28.61 %)
EPS:	CNY-0.110

FY	2021
Omsetning:	CNY1.78B
Bruttogevinst:	CNY511.92M (28.83 %)
EPS:	CNY0.0300

Financial Reports:

No articles found.

JiangSu WuZhong

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing and affordable housing development. The company was founded in 1994 and is based in Suzhou, China.